FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer.

Nitin Ohri,Balazs Halmos,Madhur K. Garg,Jeffrey M. Levsky,Haiying Cheng,R. Gucalp,William Bodner,Rafi Kabarriti,Aviva Berkowitz,Michael Yellin,Tibor Keler,Shalom Kalnicki,Chandan Guha

FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer.

2020

Nitin Ohri
Balazs Halmos
Madhur K. Garg
Jeffrey M. Levsky
Haiying Cheng
R. Gucalp
William Bodner
Rafi Kabarriti
Aviva Berkowitz
Michael Yellin
Tibor Keler
Shalom Kalnicki
Chandan Guha

9618Background: In a murine non-small cell lung cancer (NSCLC) model, we demonstrated synergy between localized radiotherapy and the dendritic cell growth factor fms-like tyrosine kinase 3 (FLT3) l...

Keywords:

Flt3 ligand
non small cell
Lung cancer
Cancer research
Medicine
stereotactic radiotherapy
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations